Ladophar is a prominent Vietnamese pharmaceutical company established in 1982, headquartered in Da Lat, Lam Dong Province. The company specializes in the manufacturing, wholesale trading, and distribution of pharmaceutical products, herbal medicines, and functional foods, with a strong focus on utilizing local medicinal herbs such as artichokes, lingzhi, and ginseng.
Operating with GMP-WHO, ISO 22000:2005, and GACP-WHO standards, Ladophar has developed a significant distribution network across Vietnam. Beyond pharmaceuticals, the company's diversified business interests have historically included the operation of hospitality facilities in Da Lat, reflecting its deep roots in the local economy of the Central Highlands.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Herbal medicine and functional foods
SIZE & FINANCIALS
Employees:201-500
Founded:1982
Ownership:public
Status:operating
STOCK
Exchange:UPCoM (Vietnam)
Ticker:LDP
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Herbal extracts, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:DHG Pharma, Traphaco, Imexpharm
LEADERSHIP
Key Executives:
Phạm Trung Kiên - Chairman of the Board
Lê Tiến Thịnh - CEO
Board Members:Nguyễn Thị Hồng Giang, Đặng Thùy Linh, Lê Xuân Thanh
LINKS
Website:ladophar.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ladophar (Lam Dong Pharmaceutical Joint Stock Company) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ladophar (Lam Dong Pharmaceutical Joint Stock Company). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.